Provided by Tiger Trade Technology Pte. Ltd.

Dare Bioscience

0.8199
+0.01071.32%
Post-market: 0.8151-0.0048-0.59%19:59 EDT
Volume:347.65K
Turnover:287.20K
Market Cap:15.89M
PE:-1.05
High:0.8500
Open:0.8000
Low:0.8000
Close:0.8092
52wk High:3.78
52wk Low:0.7500
Shares:19.38M
Float Shares:18.13M
Volume Ratio:0.14
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7826
EPS(LYR):-1.1986
ROE:-2543.13%
ROA:-39.29%
PB:-28.32
PE(LYR):-0.68

Loading ...

Dare Bioscience Q1 FY26 net loss narrows 31% to $3 million

Reuters
·
May 15

Dare Bioscience Q1 EPS $(0.20) Beats $(0.27) Estimate, Sales $152.455K Miss $984.667K Estimate

Benzinga Earnings
·
May 15

Dare Bioscience, Inc. Q1 EPS USD -0.2

THOMSON REUTERS
·
May 15

Corrected-Dare Bioscience, Inc. Q1 Net Income USD -3 Million (Corrects Amount)

THOMSON REUTERS
·
May 15

Dare Bioscience Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
May 13

Dare Bioscience reports positive interim Phase 3 results for Ovaprene

TIPRANKS
·
May 13

Daré Bioscience reports positive interim Phase 3 data for hormone-free contraceptive Ovaprene

Reuters
·
May 12

Dare Bioscience Inc - 12% of Participants Discontinued Study Due to Vaginal Odor, Down 5% From July 2025

THOMSON REUTERS
·
May 12

Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive

THOMSON REUTERS
·
May 12

Dare Bioscience Inc - No Serious Adverse Events Related to Ovaprene Device Identified

THOMSON REUTERS
·
May 12

Dare Bioscience Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
May 08

Dare Bioscience issues 195,010 units at $5 in Regulation A offering closings

Reuters
·
May 08

Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026

GlobeNewswire
·
May 07

Dare Bioscience closes Reg A offering, issues 20,000 units at $5 each

Reuters
·
Apr 21

Dare Bioscience reclassifies director Gregory Matz to Class III board seat

Reuters
·
Apr 18

Daré Bioscience announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 18

Daré Bioscience completes Regulation A sale of 3,470 units at $5 each

Reuters
·
Apr 14

Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE) and Iovance Biotherapeutics (IOVA)

TIPRANKS
·
Apr 11

Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa

TIPRANKS
·
Apr 02

Dare Bioscience Q4 EPS $(0.02) Beats $(0.43) Estimate, Sales $1.024M Beat $375.750K Estimate

Benzinga Earnings
·
Mar 27